New obesity drugs are posting surgical-scale weight-loss numbers. Is the gap closing, or are we mistaking early results for the final answer?

Committee for Medicinal Products for Human Use (CHMP) will be conducting a review of Rifadin 20 mg/ml oral suspension and ...

Qure may seek approval in the UK first while in talks with the FDA about its request for a larger, sham-controlled trial of ...

The EMA approves a new formulation of a levodopa-carbidopa combination to treat moderate-to-severe motor fluctuations in patients with Parkinson’s disease.

Home-based human papillomavirus screening for cervical cancer shows modest uptake in a diverse community setting.

The EMA says the benefits of Tavneos no longer outweigh the risks for the treatment of active granulomatosis with polyangiitis.

Researchers report the 5-year survival outcomes with lisocabtagene maraleucel in heavily pretreated patients with relapsed or ...

A post-marketing trial finds the oral antiviral achieves effective blood concentrations in at-risk children aged 6 years or older with mild-to-moderate COVID.

In patients with ulcerative colitis exposed to anti-TNF therapy, tofacitinib is linked to higher rates of clinical and ...

Fear, withdrawal symptoms, and a lack of professional support are common barriers to detoxification from opioid substitution ...

From steam injections to drug-coated balloons, the options for treating an enlarged prostate are growing fast.

New discussion around Parkinson’s treatment is putting dopamine agonists under the spotlight, with clinicians balancing motor ...